Picture of EMV Capital logo

EMVC — EMV Capital Share Price

0.000.00%
gb flag iconLast trade - 00:00
FinancialsAdventurousMicro CapNeutral

Momentum

Relative Strength (%)
1m+1.83%
3m-13.98%
6m-2.6%
1yr-12.6%
Volume Change (%)
10d/3m+54.29%
Price vs... (%)
52w High-24.19%
50d MA-3.61%
200d MA-9.11%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)2.93
PEG Ratio (f)n/a
EPS Growth (f)-70.24%
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value0.39
Price to Tang. Book0.41
Price to Free Cashflown/a
Price to Sales4.24
EV to EBITDA0.68

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital49.13%
Return on Equity79.97%
Operating Margin613.11%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202631st Dec 2027
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2026 / 2027

Blurred out image of EMV Capital EPS forecast chart

Profile Summary

EMV Capital plc is a United Kingdom-based deep tech and life sciences venture capital (VC) investment group with an international portfolio of companies. The Company identifies, invests in, and builds high-growth companies in the United Kingdom and internationally. It focuses on generating returns for investors from the sectors and technologies. The Company has a portfolio of approximately 70 companies with a focus on life sciences, industrials, robotics & artificial intelligence (AI), and sustainability. Its portfolio includes AMR Bio, Wanda Health, Deeptech Recycling Technologies, EpiBone, Sofant Technologies, Q-Bot, and others. Its portfolio, Glycotest, is a liver disease diagnostics company commercializing novel and unique blood tests for life-threatening liver cancers and fibrosis-cirrhosis. ProAxsis Limited is a commercial biomarker-led research company supporting drug development and clinical research through specialist biomarker insights.

Directors

Last Annual
December 31st, 2025
Last Interim
June 30th, 2026
Incorporated
April 12th, 2012
Public Since
September 16th, 2013
No. of Employees
21
Sector
Investment Banking & Investment Services
Industry
Financials
Exchange
gb flag iconLondon Stock Exchange
Shares in Issue
27,967,532

EMVC Share Price Performance

Upcoming Events for EMVC

Similar to EMVC

Picture of 3i logo

3i

gb flag iconLondon Stock Exchange

Picture of Aberdeen logo

Aberdeen

gb flag iconLondon Stock Exchange

Picture of Achilles Investment logo

Achilles Investment

gb flag iconLondon Stock Exchange

Picture of Reabold Resources logo

Reabold Resources

gb flag iconLondon Stock Exchange

Picture of Agronomics logo

Agronomics

gb flag iconLondon Stock Exchange

FAQ